Immunocore Holdings plc (IMCR) — Revenue

Annual figures by fiscal year, from SEC filings.

2021: $4.08M2022: $174.36M2023: $249.43M2024: $310.20M2025: $400.02M$400.02M
2021Revenue (USD)2025
Fiscal YearRevenueChange YoY
2025$400.02M+29.0%
2024$310.20M+24.4%
2023$249.43M+43.1%
2022$174.36M+4175.6%
2021$4.08M